119 related articles for article (PubMed ID: 18615101)
1. The expression of 16 genes related to the cell of origin and immune response predicts survival in elderly patients with diffuse large B-cell lymphoma treated with CHOP and rituximab.
Jais JP; Haioun C; Molina TJ; Rickman DS; de Reynies A; Berger F; Gisselbrecht C; Brière J; Reyes F; Gaulard P; Feugier P; Labouyrie E; Tilly H; Bastard C; Coiffier B; Salles G; Leroy K;
Leukemia; 2008 Oct; 22(10):1917-24. PubMed ID: 18615101
[TBL] [Abstract][Full Text] [Related]
2. Distinct Molecular Subtypes of Diffuse Large B Cell Lymphoma Patients Treated with Rituximab-CHOP Are Associated with Different Clinical Outcomes and Molecular Mechanisms.
Yu H; Peng S; Han S; Chen X; Lyu Q; Lei T
Biomed Res Int; 2021; 2021():5514726. PubMed ID: 34250086
[TBL] [Abstract][Full Text] [Related]
3. CRISPR/Cas9-Mediated Foxp1 Silencing Restores Immune Surveillance in an Immunocompetent A20 Lymphoma Model.
Felce SL; Anderson AP; Maguire S; Gascoyne DM; Armstrong RN; Wong KK; Li D; Banham AH
Front Oncol; 2020; 10():448. PubMed ID: 32309216
[TBL] [Abstract][Full Text] [Related]
4. Retracted: Distinct Molecular Subtypes of Diffuse Large B Cell Lymphoma Patients Treated with Rituximab-CHOP Are Associated with Different Clinical Outcomes and Molecular Mechanisms.
International BR
Biomed Res Int; 2024; 2024():9846925. PubMed ID: 38550212
[TBL] [Abstract][Full Text] [Related]
5. Stromal gene signatures in large-B-cell lymphomas.
Lenz G; Wright G; Dave SS; Xiao W; Powell J; Zhao H; Xu W; Tan B; Goldschmidt N; Iqbal J; Vose J; Bast M; Fu K; Weisenburger DD; Greiner TC; Armitage JO; Kyle A; May L; Gascoyne RD; Connors JM; Troen G; Holte H; Kvaloy S; Dierickx D; Verhoef G; Delabie J; Smeland EB; Jares P; Martinez A; Lopez-Guillermo A; Montserrat E; Campo E; Braziel RM; Miller TP; Rimsza LM; Cook JR; Pohlman B; Sweetenham J; Tubbs RR; Fisher RI; Hartmann E; Rosenwald A; Ott G; Muller-Hermelink HK; Wrench D; Lister TA; Jaffe ES; Wilson WH; Chan WC; Staudt LM;
N Engl J Med; 2008 Nov; 359(22):2313-23. PubMed ID: 19038878
[TBL] [Abstract][Full Text] [Related]
6. Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue.
Scott DW; Wright GW; Williams PM; Lih CJ; Walsh W; Jaffe ES; Rosenwald A; Campo E; Chan WC; Connors JM; Smeland EB; Mottok A; Braziel RM; Ott G; Delabie J; Tubbs RR; Cook JR; Weisenburger DD; Greiner TC; Glinsmann-Gibson BJ; Fu K; Staudt LM; Gascoyne RD; Rimsza LM
Blood; 2014 Feb; 123(8):1214-7. PubMed ID: 24398326
[TBL] [Abstract][Full Text] [Related]
7. Poor concordance among nine immunohistochemistry classifiers of cell-of-origin for diffuse large B-cell lymphoma: implications for therapeutic strategies.
Coutinho R; Clear AJ; Owen A; Wilson A; Matthews J; Lee A; Alvarez R; Gomes da Silva M; Cabeçadas J; Calaminici M; Gribben JG
Clin Cancer Res; 2013 Dec; 19(24):6686-95. PubMed ID: 24122791
[TBL] [Abstract][Full Text] [Related]
8. Genetic landscape of hepatitis B virus-associated diffuse large B-cell lymphoma.
Ren W; Ye X; Su H; Li W; Liu D; Pirmoradian M; Wang X; Zhang B; Zhang Q; Chen L; Nie M; Liu Y; Meng B; Huang H; Jiang W; Zeng Y; Li W; Wu K; Hou Y; Wiman KG; Li Z; Zhang H; Peng R; Zhu S; Pan-Hammarström Q
Blood; 2018 Jun; 131(24):2670-2681. PubMed ID: 29545328
[TBL] [Abstract][Full Text] [Related]
9. PrognoScan: a new database for meta-analysis of the prognostic value of genes.
Mizuno H; Kitada K; Nakai K; Sarai A
BMC Med Genomics; 2009 Apr; 2():18. PubMed ID: 19393097
[TBL] [Abstract][Full Text] [Related]
10. An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia.
Metzeler KH; Hummel M; Bloomfield CD; Spiekermann K; Braess J; Sauerland MC; Heinecke A; Radmacher M; Marcucci G; Whitman SP; Maharry K; Paschka P; Larson RA; Berdel WE; Büchner T; Wörmann B; Mansmann U; Hiddemann W; Bohlander SK; Buske C; ;
Blood; 2008 Nov; 112(10):4193-201. PubMed ID: 18716133
[TBL] [Abstract][Full Text] [Related]
11. Abrogation of the G2 cell cycle checkpoint associated with overexpression of HSIX1: a possible mechanism of breast carcinogenesis.
Ford HL; Kabingu EN; Bump EA; Mutter GL; Pardee AB
Proc Natl Acad Sci U S A; 1998 Oct; 95(21):12608-13. PubMed ID: 9770533
[TBL] [Abstract][Full Text] [Related]
12. Dangers of using "optimal" cutpoints in the evaluation of prognostic factors.
Altman DG; Lausen B; Sauerbrei W; Schumacher M
J Natl Cancer Inst; 1994 Jun; 86(11):829-35. PubMed ID: 8182763
[No Abstract] [Full Text] [Related]
13. Treated chronic hepatitis B is a good prognostic factor of diffuse large B-cell lymphoma.
Park J; Chung SW; Lee YB; Shin H; Hur MH; Cho H; Park MK; Youk J; Lee JY; Lee JO; Yu SJ; Kim YJ; Yoon JH; Kim TM; Lee JH
Clin Mol Hepatol; 2023 Jul; 29(3):794-809. PubMed ID: 37196991
[TBL] [Abstract][Full Text] [Related]
14. Isoform-specific knockdown of long and intermediate prolactin receptors interferes with evolution of B-cell neoplasms.
Taghi Khani A; Kumar A; Sanchez Ortiz A; Radecki KC; Aramburo S; Lee SJ; Hu Z; Damirchi B; Lorenson MY; Wu X; Gu Z; Stohl W; Sanz I; Meffre E; Müschen M; Forman SJ; Koff JL; Walker AM; Swaminathan S
Commun Biol; 2023 Mar; 6(1):295. PubMed ID: 36941341
[TBL] [Abstract][Full Text] [Related]
15. Artificial Intelligence Predicted Overall Survival and Classified Mature B-Cell Neoplasms Based on Immuno-Oncology and Immune Checkpoint Panels.
Carreras J; Roncador G; Hamoudi R
Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358737
[TBL] [Abstract][Full Text] [Related]
16. APOBEC3G protects the genome of human cultured cells and mice from radiation-induced damage.
Britan-Rosich Y; Ma J; Kotler E; Hassan F; Botvinnik A; Smith Y; Moshel O; Nasereddin A; Sharma G; Pikarsky E; Ross S; Kotler M
FEBS J; 2023 Apr; 290(7):1822-1839. PubMed ID: 36325681
[TBL] [Abstract][Full Text] [Related]
17. Oncological Treatment-Related Fatigue in Oncogeriatrics: A Scoping Review.
André L; Antherieu G; Boinet A; Bret J; Gilbert T; Boulahssass R; Falandry C
Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35626074
[TBL] [Abstract][Full Text] [Related]
18. A Conserved uORF Regulates APOBEC3G Translation and Is Targeted by HIV-1 Vif Protein to Repress the Antiviral Factor.
Libre C; Seissler T; Guerrero S; Batisse J; Verriez C; Stupfler B; Gilmer O; Cabrera-Rodriguez R; Weber MM; Valenzuela-Fernandez A; Cimarelli A; Etienne L; Marquet R; Paillart JC
Biomedicines; 2021 Dec; 10(1):. PubMed ID: 35052693
[TBL] [Abstract][Full Text] [Related]
19. Cohesin Core Complex Gene Dosage Contributes to Germinal Center Derived Lymphoma Phenotypes and Outcomes.
Rivas MA; Durmaz C; Kloetgen A; Chin CR; Chen Z; Bhinder B; Koren A; Viny AD; Scharer CD; Boss JM; Elemento O; Mason CE; Melnick AM
Front Immunol; 2021; 12():688493. PubMed ID: 34621263
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and prognostic value of secreted protein acidic and rich in cysteine in the diffuse large B-cell lymphoma.
Pan PJ; Liu JX
World J Clin Cases; 2021 Aug; 9(22):6287-6299. PubMed ID: 34434995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
